Skip to content

Psychometric Properties Mobility Measures MS

Psychometric Properties of Mobility, Beyond Walking Speed, in Multiple Sclerosis: a Multi-center Study.

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02339688
Acronym
MCS-III-MOB
Enrollment
254
Registered
2015-01-15
Start date
2014-10-31
Completion date
2016-06-30
Last updated
2016-06-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Multiple Sclerosis

Brief summary

Current study will investigate the quality (psychometric properties) and clinical utility of several mobility measures, according to disability level. Therefore, several aspects will be inquired: * Was there an effect of rehabilitation * Is the measure able to detect change over time? And thus the change exceed measurement error and is it clinically important (responsiveness) * Does the measure assess what it claims to measure (validity) * Is the measure able to differentiate all performances of the patients, inclusively the very good and very bad performances (floor and ceiling effects) * Does the measure gives similar results under consistent test conditions on another testing day (reliability) Worldwide, theoretical approaches to physical therapy and rehabilitation in Multiple Sclerosis often appear significantly different. Since the present research protocol will be performed at different centers across European countries (and US sites), this multi-center study can additionally be applied for mapping the volume and content of rehabilitation, as well as the differential impact of diverse rehabilitation approaches and training volume on mobility, for several disability levels. Some health-economic analyses will be performed to examine what the approximate cost of rehabilitation compared to effects is and what drivers of costs are (setting, equipment, staff).

Interventions

assessment pre and post conventional MS rehabilitation

Sponsors

Dept Neurological Rehabilitation Reha Zentrum Münster Gröben
CollaboratorUNKNOWN
National MS Center Melsbroek
CollaboratorOTHER
Revalidatie & MS Centrum Overpelt
CollaboratorOTHER
De Mick
CollaboratorUNKNOWN
Charles University, Czech Republic
CollaboratorOTHER
Danish MS Hospitals, Haslev and Ry
CollaboratorOTHER
Masku Neurological Rehabilitation Center
CollaboratorUNKNOWN
Quellenhof
CollaboratorUNKNOWN
Fondazione Don Carlo Gnocchi Onlus
CollaboratorOTHER
Italian Multiple Sclerosis Foundation
CollaboratorOTHER
Sheba Medical Center
CollaboratorOTHER_GOV
MS-Senteret Hakadal
CollaboratorUNKNOWN
Haukeland University Hospital
CollaboratorOTHER
MS Rehabilitation Center Borne Sulinowo
CollaboratorUNKNOWN
Clinical center Belgrado
CollaboratorUNKNOWN
Eugenia Epalza Rehabilitation Center, Bilbao, Spain
CollaboratorOTHER
Cleveland Mellen MS Center
CollaboratorUNKNOWN
University of Colorado, Denver
CollaboratorOTHER
Queen's University
CollaboratorOTHER
Shepherd Center Atlanta
CollaboratorUNKNOWN
St. Louis University
CollaboratorOTHER
Hasselt University
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Diagnosis of MS according to McDonald criteria24, * Expanded Disability Status Scale25 (EDSS) ≥ 2 and ≤ 6.5 as determined by neurologists or trained clinician * no relapse within the last month * no changes in disease modifying treatment and no corticoid-therapy within the last month * receive at least 10 sessions of physical therapy (in- or outpatient rehabilitation), with a maximum duration of 3 months

Exclusion criteria

* other medical conditions interfering with mobility (e.g. stroke, pregnancy, fractures, …) * other neurological impairments with permanent damage (stroke, Parkinson, …) * MS-like syndromes such as neuromyelitis optica * not able to understand and execute simple instructions

Design outcomes

Primary

MeasureTime frame
Performance Scale mobility (PS-mob)day 1 and at the end of the rehabilitation, an expected average of three months
Two minute walk test (2MWT)day 1 and at the end of the rehabilitation, an expected average of three months
Four Square Step Test (FSST)day 1 and at the end of the rehabilitation, an expected average of three months
5 repetition sit-to-stand test (5STS-test)day 1 and at the end of the rehabilitation, an expected average of three months
Modified 5 repetition sit-to-stand test (mod 5STS-test)day 1 and at the end of the rehabilitation, an expected average of three months
Rivermead Mobility Index (RMI)day 1 and at the end of the rehabilitation, an expected average of three months
Multiple Sclerosis Walking Scale-12 (MSWS-12)day 1 and at the end of the rehabilitation, an expected average of three months
Timed 25-Foot Walk test (T25FW)day 1 and at the end of the rehabilitation, an expected average of three months
Timed up and go (TUG), TUGcognitiveday 1 and at the end of the rehabilitation, an expected average of three months

Secondary

MeasureTime frame
Berg Balance Scale (BBS)day 1 and at the end of the rehabilitation, an expected average of three months
Dynamic Gait index (DGI)day 1 and at the end of the rehabilitation, an expected average of three months
Activities-specific Balance Confidence Scale (ABC)day 1 and at the end of the rehabilitation, an expected average of three months
Trunk Impairment Scale, modified Norwegian version (TIS-modNV)day 1 and at the end of the rehabilitation, an expected average of three months
International Physical Activity Questionnaire (IPAQ)day 1 and at the end of the rehabilitation, an expected average of three months
Timed Up and Go, manualday 1 and at the end of the rehabilitation, an expected average of three months

Countries

Belgium

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026